Regulation of ERK kinase by MEK1 kinase inhibition in the brain

Journal of Biological Chemistry

Volumn 290, Issue 26, 2015, Pages 16319-16329

  Tassin, Tara C ^a   Benavides, David R ^b   Plattner, Florian ^a   Nishi, Akinori ^c   Bibb, James A ^a,d  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^b JOHNS HOPKINS HOSPITAL   (United States)

^c KURUME UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^d UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BRAIN; CHEMICAL ACTIVATION; ENZYMES; FEEDBACK; MAMMALS; PROTEINS; SIGNAL TRANSDUCTION;

BRAIN CIRCUITRY; BRAIN FUNCTIONS; FEEDBACK INHIBITION; INTRACELLULAR SIGNALS; IONOTROPIC GLUTAMATE RECEPTORS; KINASE INHIBITION; PROTEIN PHOSPHATASE-1; PROTEIN PHOSPHORYLATION;

PHOSPHORYLATION;

CYCLIN DEPENDENT KINASE 5; IONOTROPIC RECEPTOR; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE KINASE 1; PROTEIN CDK1; PROTEIN SERINE THREONINE KINASE; UNCLASSIFIED DRUG; CYCLIN DEPENDENT KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3;

ACUTE STRESS; ADULT; ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN TISSUE; CONTROLLED STUDY; CORPUS STRIATUM; DOPAMINERGIC TRANSMISSION; ENZYME ACTIVE SITE; ENZYME INHIBITION; ENZYME PHOSPHORYLATION; FORCED SWIM TEST; GLUTAMATERGIC SYNAPSE; IN VITRO STUDY; IN VIVO STUDY; MALE; MOUSE; NEGATIVE FEEDBACK; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN INTERACTION; TASK PERFORMANCE; ANIMAL; BRAIN; C57BL MOUSE; CHEMISTRY; ENZYMOLOGY; GENETICS; METABOLISM; PHOSPHORYLATION; PROTEIN MOTIF;

AMINO ACID MOTIFS; ANIMALS; BRAIN; CDC2 PROTEIN KINASE; CYCLIN-DEPENDENT KINASE 5; MALE; MAP KINASE KINASE 1; MICE; MICE, INBRED C57BL; MITOGEN-ACTIVATED PROTEIN KINASE 3; PHOSPHORYLATION;

EID: 84931285081     PISSN: 00219258     EISSN: 1083351X     Source Type: Journal    
DOI: 10.1074/jbc.M115.654897     Document Type: Article

References (79)

1. Wang, X., Wang, Z., Yao, Y., Li, J., Zhang, X., Li, C., Cheng, Y., Ding, G., Liu, L., and Ding, Z. (2011) Essential role of ERK activation in neurite outgrowth induced by α-lipoic acid. Biochim. Biophys. Acta 1813, 827-838
2. Atwal, J. K., Massie, B., Miller, F. D., and Kaplan, D. R. (2000) The TrkBShc site signals neuronal survival and local axon growth via MEK and P13-kinase. Neuron 27, 265-277
3. Xifró, X., Miñano-Molina, A. J., Saura, C. A., and Rodríguez-Álvarez, J. (2014) Ras protein activation is a key event in activity-dependent survival of cerebellar granule neurons. J. Biol. Chem. 289, 8462-8472
4. English, J. D., and Sweatt, J. D. (1996) Activation of p42 mitogen-activated protein kinase in hippocampal long term potentiation. J. Biol. Chem. 271, 24329-24332
5. Bading, H., and Greenberg, M. E. (1991) Stimulation of protein tyrosine phosphorylation by NMDA receptor activation. Science 253, 912-914
6. Kelly, A., Laroche, S., and Davis, S. (2003) Activation of mitogen-activated protein kinase/extracellular signal-regulated kinase in hippocampal circuitry is required for consolidation and reconsolidation of recognition memory. J. Neurosci. 23, 5354-5360
7. Schafe, G. E., Nadel, N. V., Sullivan, G. M., Harris, A., and Le Doux, J. E. (1999) Memory consolidation for contextual and auditory fear conditioning is dependent on protein synthesis, PKA, and MAPkinase. Learn. Mem. 6, 97-110
8. Schafe, G. E., Atkins, C. M., Swank, M. W., Bauer, E. P., Sweatt, J. D., and Le Doux, J. E. (2000) Activation of ERK/MAP kinase in the amygdala is required for memory consolidation of Pavlovian fear conditioning. J. Neurosci. 20, 8177-8187
9. Selcher, J. C., Atkins, C. M., Trzaskos, J. M., Paylor, R., and Sweatt, J. D. (1999) A necessity for MAP kinase activation in mammalian spatial learning. Learn. Mem. 6, 478-490
10. Kyosseva, S. V., Elbein, A. D., Hutton, T. L., Griffin, S. T., Mrak, R. E., Sturner, W. Q., and Karson, C. N. (2000) Increased levels of transcription factors Elk-1, cyclic adenosine monophosphate response element-binding protein, and activating transcription factor 2 in the cerebellar vermis of schizophrenic patients. Arch. Gen. Psychiatry 57, 685-691
11. Kyosseva, S. V., Elbein, A. D., Griffin, W. S., Mrak, R. E., Lyon, M., and Karson, C. N. (1999) Mitogen-activated protein kinases in schizophrenia. Biol. Psychiatry 46, 689-696
12. Todorova, V. K., Elbein, A. D., and Kyosseva, S. V. (2003) Increased expression of c-Jun. transcription factor in cerebellar vermis of patients with schizophrenia. Neuropsychopharmacology 28, 1506-1514
13. Dwivedi, Y., Rizavi, H. S., Roberts, R. C., Conley, R. C., Tamminga, C. A., and Pandey, G. N. (2001) Reduced activation and expression of ERK1/2 MAP kinase in the post-mortem brain of depressed suicide subjects. J. Neurochem. 77, 916-928
14. Wang, Z., Gu, J., Wang, X., Xie, K., Luan, Q., Wan, N., Zhang, Q., Jiang, H., and Liu, D. (2013) Antidepressant-like activity of resveratrol treatment in the forced swim test and tail suspension test in mice: the HPA axis, BDNF expression and phosphorylation of ERK. Pharmacol. Biochem. Behav. 112, 104-110
15. Duman, C. H., Schlesinger, L., Kodama, M., Russell, D. S., and Duman, R. S. (2007) A role for MAP kinase signaling in behavioral models of depression and antidepressant treatment. Biol. psychiatry 61, 661-670
16. Huang, T. Y., and Lin, C. H. (2006) Role of amygdala MAPK activation on immobility behavior of forced swim rats. Behav. Brain Res. 173, 104-111
17. Qi, X., Lin, W., Wang, D., Pan, Y., Wang, W., and Sun, M. (2009) A role for the extracellular signal-regulated kinase signal pathway in depressive-like behavior. Behav. Brain Res. 199, 203-209
18. Qi, X., Lin, W., Li, J., Pan, Y., and Wang, W. (2006) The depressive-like behaviors are correlated with decreased phosphorylation of mitogen-activated protein kinases in rat brain following chronic forced swim stress. Behav. Brain Res. 175, 233-240
19. Qi, X., Lin, W., Li, J., Li, H., Wang, W., Wang, D., and Sun, M. (2008) Fluoxetine increases the activity of the ERK-CREB signal system and alleviates the depressive-like behavior in rats exposed to chronic forced swim stress. Neurobiol. Dis. 31, 278-285
20. Valjent, E., Corvol, J. C., Pages, C., Besson, M. J., Maldonado, R., and Caboche, J. (2000) Involvement of the extracellular signal-regulated kinase cascade for cocaine-rewarding properties. J. Neurosci. 20, 8701-8709
21. Lu, L., Koya, E., Zhai, H., Hope, B. T., and Shaham, Y. (2006) Role of ERK in cocaine addiction. Trends Neurosci. 29, 695-703
22. Yuan, L. L., Adams, J. P., Swank, M., Sweatt, J. D., and Johnston, D. (2002) Protein kinase modulation of dendritic K+ channels in hippocampus involves a mitogen-activated protein kinase pathway. J. Neurosci. 22, 4860-4868
23. Qin, Y., Zhu, Y., Baumgart, J. P., Stornetta, R. L., Seidenman, K., Mack, V., Van Aelst, L., and Zhu, J. J. (2005) State-dependent Ras signaling and AMPA receptor trafficking. Genes Dev. 19, 2000-2015
24. Seese, R. R., Maske, A. R., Lynch, G., and Gall, C. M. (2014) Long-term memory deficits are associated with elevated synaptic ERK1/2 activation and reversed by mGluR5 antagonism in an animal model of autism. Neuropsychopharmacology 39, 1664-1673
25. Kumar, R. A., Kara Mohamed, S., Sudi, J., Conrad, D. F., Brune, C., Badner, J. A., Gilliam, T. C., Nowak, N. J., Cook, E. H., Jr., Dobyns, W. B., and Christian, S. L. (2008) Recurrent 16p11.2 microdeletions in autism. Hum. Mol. Genet. 17, 628-638
26. Kim, S. H., Markham, J. A., Weiler, I. J., and Greenough, W. T. (2008) Aberrant early-phase ERK inactivation impedes neuronal function in fragile X syndrome. Proc. Natl. Acad. Sci. U. S. A. 105, 4429-4434
27. Subramaniam, S., Zirrgiebel, U., Von Bohlen Und Halbach, O., Strelau, J., Laliberté, C., Kaplan, D. R., and Unsicker, K. (2004) ERK activation promotes neuronal degeneration predominantly through plasma membrane damage and independently of caspase-3. J. Cell Biol. 165, 357-369
28. Rosen, L. B., Ginty, D. D., Weber, M. J., and Greenberg, M. E. (1994) Membrane depolarization and calcium influx stimulate MEK and MAP kinase via activation of Ras. Neuron 12, 1207-1221
29. Martin, K. C., Michael, D., Rose, J. C., Barad, M., Casadio, A., Zhu, H., and Kandel, E. R. (1997) MAP kinase translocates into the nucleus of the presynaptic cell and is required for long-term facilitation in Aplysia. Neuron 18, 899-912
30. Vossler, M. R., Yao, H., York, R. D., Pan, M. G., Rim, C. S., and Stork, P. J. (1997) cAMP activates MAP kinase and Elk-1 through a B-Raf- and Rap1-dependent pathway. Cell 89, 73-82
31. York, R. D., Yao, H., Dillon, T., Ellig, C. L., Eckert, S. P., McCleskey, E. W., and Stork, P. J. (1998) Rap1 mediates sustained MAP kinase activation induced by nerve growth factor. Nature 392, 622-626
32. Yao, H., York, R. D., Misra-Press, A., Carr, D. W., and Stork, P. J. (1998) The cyclic adenosine monophosphate-dependent protein kinase (PKA) is required for the sustained activation of mitogen-activated kinases and gene expression by nerve growth factor. J. Biol. Chem. 273, 8240-8247
33. Segal, R. A., and Greenberg, M. E. (1996) Intracellular signaling pathways activated by neurotrophic factors. Annu. Rev. Neurosci. 19, 463-489
34. Min, X., Akella, R., He, H., Humphreys, J. M., Tsutakawa, S. E., Lee, S. J., Tainer, J. A., Cobb, M. H., and Goldsmith, E. J. (2009) The structure of the MAP2K MEK6 reveals an autoinhibitory dimer. Structure 17, 96-104
35. Gardner, A. M., Vaillancourt, R. R., Lange-Carter, C. A., and Johnson, G. L. (1994) MEK-1 phosphorylation by MEK kinase, Raf, and mitogen-activated protein kinase: analysis of phosphopeptides and regulation of activity. Mol. Biol. Cell 5, 193-201
36. Eblen, S. T., Slack-Davis, J. K., Tarcsafalvi, A., Parsons, J. T., Weber, M. J., and Catling, A. D. (2004) Mitogen-activated protein kinase feedback phosphorylation regulates MEK1 complex formation and activation during cellular adhesion. Mol. Cell. Biol. 24, 2308-2317
37. Catalanotti, F., Reyes, G., Jesenberger, V., Galabova-Kovacs, G., De Matos Simoes, R., Carugo, O., and Baccarini, M. (2009) A Mek1-Mek2 heterodimer determines the strength and duration of the Erk signal. Nat. Struct. Mol. Biol. 16, 294-303
38. Rossomando, A. J., Dent, P., Sturgill, T. W., and Marshak, D. R. (1994) Mitogen-activated protein kinase kinase 1 (MKK1) is negatively regulated by threonine phosphorylation. Mol. Cell. Biol. 14, 1594-1602
39. Sharma, P., Veeranna, Sharma, M., Amin, N. D., Sihag, R. K., Grant, P., Ahn, N., Kulkarni, A. B., and Pant, H. C. (2002) Phosphorylation of MEK1 by cdk5/p35 down-regulates the mitogen-activated protein kinase pathway. J. Biol. Chem. 277, 528-534
40. Sharma, M., Hanchate, N. K., Tyagi, R. K., and Sharma, P. (2007) Cyclin dependent kinase 5 (Cdk5) mediated inhibition of the MAP kinase pathway results in CREB down regulation and apoptosis in PC12 cells. Biochem. Biophys. Res. Commun. 358, 379-384
41. Hayashi, K., Pan, Y., Shu, H., Ohshima, T., Kansy, J. W., White, C. L., 3rd, Tamminga, C. A., Sobel, A., Curmi, P. A., Mikoshiba, K., and Bibb, J. A. (2006) Phosphorylation of the tubulin-binding protein, stathmin, by Cdk5 and MAP kinases in the brain. J. Neurochem. 99, 237-250
42. Sahin, B., Shu, H., Fernandez, J., El-Armouche, A., Molkentin, J. D., Nairn, A. C., and Bibb, J. A. (2006) Phosphorylation of protein phosphatase inhibitor-1 by protein kinase C. J. Biol. Chem. 281, 24322-24335
43. Hawasli, A. H., Benavides, D. R., Nguyen, C., Kansy, J. W., Hayashi, K., Chambon, P., Greengard, P., Powell, C. M., Cooper, D. C., and Bibb, J. A. (2007) Cyclin-dependent kinase 5 governs learning and synaptic plasticity via control of NMDAR degradation. Nat. Neurosci. 10, 880-886
44. Hamada, M., Hendrick, J. P., Ryan, G. R., Kuroiwa, M., Higashi, H., Tanaka, M., Nairn, A. C., Greengard, P., and Nishi, A. (2005) Nicotine regulates DARPP-32 (dopamine- and cAMP-regulated phosphoprotein of 32 kDa) phosphorylation at multiple sites in neostriatal neurons. J. Pharmacol. Exp. Ther. 315, 872-878
45. Plattner, F., Hernández, A., Kistler, T. M., Pozo, K., Zhong, P., Yuen, E. Y., Tan, C., Hawasli, A. H., Cooke, S. F., Nishi, A., Guo, A., Wiederhold, T., Yan, Z., and Bibb, J. A. (2014) Memory enhancement by targeting Cdk5 regulation of NR2B. Neuron 81, 1070-1083
46. Takahashi, S., Ohshima, T., Cho, A., Sreenath, T., Iadarola, M. J., Pant, H. C., Kim, Y., Nairn, A. C., Brady, R. O., Greengard, P., and Kulkarni, A. B. (2005) Increased activity of cyclin-dependent kinase 5 leads to attenuation of cocaine-mediated dopamine signaling. Proc. Natl. Acad. Sci. U. S. A. 102, 1737-1742
47. Songyang, Z., Lu, K. P., Kwon, Y. T., Tsai, L. H., Filhol, O., Cochet, C., Brickey, D. A., Soderling, T. R., Bartleson, C., Graves, D. J., De Maggio, A. J., Hoekstra, M. F., Blenis, J., Hunter, T., and Cantley, L. C. (1996) A structural basis for substrate specificities of protein Ser/Thr kinases: primary sequence preference of casein kinases I and II, NIMA, phosphorylase kinase, calmodulin-dependent kinase II, CDK5, and Erk1. Mol. Cell. Biol. 16, 6486-6493
48. Brunet, A., Pagès, G., and Pouysségur, J. (1994) Growth factor-stimulated MAP kinase induces rapid retrophosphorylation and inhibition of MAP kinase kinase (MEK1). FEBS Lett. 346, 299-303
49. Van Scyoc, W. S., Holdgate, G. A., Sullivan, J. E., and Ward, W. H. (2008) Enzyme kinetics and binding studies on inhibitors of MEK protein kinase. Biochemistry 47, 5017-5027
50. Fersht, A. (1985) Enzyme Structure and Mechanism, 2nd ed., W. H. Freeman, New York
51. Philibin, S. D., Hernandez, A., Self, D. W., and Bibb, J. A. (2011) Striatal signal transduction and drug addiction. Front. Neuroanat. 5, 60
52. Nishi, A., Kuroiwa, M., and Shuto, T. (2011) Mechanisms for the modulation of dopamine d (1) receptor signaling in striatal neurons. Front. Neuroanat. 5, 43
53. Valjent, E., Pascoli, V., Svenningsson, P., Paul, S., Enslen, H., Corvol, J. C., Stipanovich, A., Caboche, J., Lombroso, P. J., Nairn, A. C., Greengard, P., Hervé, D., and Girault, J. A. (2005) Regulation of a protein phosphatase cascade allows convergent dopamine and glutamate signals to activate ERK in the striatum. Proc. Natl. Acad. Sci. U. S. A. 102, 491-496
54. Bertran-Gonzalez, J., Herve, D., Girault, J. A., and Valjent, E. (2010) What is the degree of segregation between striatonigral and striatopallidal projections? Front. Neuroanat. 4, 136
55. Nishi, A., Snyder, G. L., Nairn, A. C., and Greengard, P. (1999) Role of calcineurin and protein phosphatase-2A in the regulation of DARPP-32 dephosphorylation in neostriatal neurons. J. Neurochem. 72, 2015-2021
56. Li, R., Xie, D. D., Dong, J. H., Li, H., Li, K. S., Su, J., Chen, L. Z., Xu, Y. F., Wang, H. M., Gong, Z., Cui, G. Y., Yu, X., Wang, K., Yao, W., Xin, T., Li, M. Y., Xiao, K. H., An, X. F., Huo, Y., Xu, Z. G., Sun, J. P., and Pang, Q. (2014) Molecular mechanism of ERK dephosphorylation by striatal-enriched protein tyrosine phosphatase. J. Neurochem. 128, 315-329
57. Mitsuhashi, S., Shima, H., Tanuma, N., Matsuura, N., Takekawa, M., Urano, T., Kataoka, T., Ubukata, M., and Kikuchi, K. (2003) Usage of tautomycetin, a novel inhibitor of protein phosphatase 1(PP1), reveals that PP1 is a positive regulator of Raf-1 in vivo. J. Biol. Chem. 278, 82-88
58. Yu, L. G., Packman, L. C., Weldon, M., Hamlett, J., and Rhodes, J. M. (2004) Protein phosphatase 2A, a negative regulator of the ERK signaling pathway, is activated by tyrosine phosphorylation of putative HLA class II-associated protein I (PHAPI)/pp32 in response to the antiproliferative lectin, jacalin. J. Biol. Chem. 279, 41377-41383
59. Chen, H. J., Rojas-Soto, M., Oguni, A., and Kennedy, M. B. (1998) A synaptic Ras-GTPase activating protein (p135 SynGAP) inhibited by CaM kinase II. Neuron 20, 895-904
60. Komiyama, N. H., Watabe, A. M., Carlisle, H. J., Porter, K., Charlesworth, P., Monti, J., Strathdee, D. J., O'Carroll, C. M., Martin, S. J., Morris, R. G., O'Dell, T. J., and Grant, S. G. (2002) SynGAP regulates ERK/MAPK signaling, synaptic plasticity, and learning in the complex with postsynaptic density 95 and NMDA receptor. J. Neurosci. 22, 9721-9732
61. Sava, A., Formaggio, E., Carignani, C., Andreetta, F., Bettini, E., and Griffante, C. (2012) NMDA-induced ERK signalling is mediated by NR2B subunit in rat cortical neurons and switches from positive to negative depending on stage of development. Neuropharmacology 62, 925-932
62. Ehlers, M. D. (2000) Reinsertion or degradation of AMPA receptors determined by activity-dependent endocytic sorting. Neuron 28, 511-525
63. Kameyama, K., Lee, H. K., Bear, M. F., and Huganir, R. L. (1998) Involvement of a postsynaptic protein kinase A substrate in the expression of homosynaptic long-term depression. Neuron 21, 1163-1175
64. Lee, H. K., Takamiya, K., Han, J. S., Man, H., Kim, C. H., Rumbaugh, G., Yu, S., Ding, L., He, C., Petralia, R. S., Wenthold, R. J., Gallagher, M., and Huganir, R. L. (2003) Phosphorylation of the AMPA receptor GluR1 subunit is required for synaptic plasticity and retention of spatial memory. Cell 112, 631-643
65. Bibb, J. A., Mayford, M. R., Tsien, J. Z., and Alberini, C. M. (2010) Cognition enhancement strategies. J. Neurosci. 30, 14987-14992
66. Shors, T. J., and Servatius, R. J. (1995) Stress-induced sensitization and facilitated learning require NMDA receptor activation. Neuroreport 6, 677-680
67. Yuen, E. Y., Liu, W., Karatsoreos, I. N., Ren, Y., Feng, J., McEwen, B. S., and Yan, Z. (2011) Mechanisms for acute stress-induced enhancement of glutamatergic transmission and working memory. Mol. Psychiatry 16, 156-170
68. Porsolt, R. D., Anton, G., Blavet, N., and Jalfre, M. (1978) Behavioural despair in rats: a new model sensitive to antidepressant treatments. Eur. J. Pharmacol. 47, 379-391
69. Eblen, S. T., Slack, J. K., Weber, M. J., and Catling, A. D. (2002) Rac-PAK signaling stimulates extracellular signal-regulated kinase (ERK) activation by regulating formation of MEK1-ERK complexes. Mol. Cell. Biol. 22, 6023-6033
70. Slack-Davis, J. K., Eblen, S. T., Zecevic, M., Boerner, S. A., Tarcsafalvi, A., Diaz, H. B., Marshall, M. S., Weber, M. J., Parsons, J. T., and Catling, A. D. (2003) PAK1 phosphorylation of MEK1 regulates fibronectin-stimulated MAPK activation. J. Cell Biol. 162, 281-291
71. Frost, J. A., Steen, H., Shapiro, P., Lewis, T., Ahn, N., Shaw, P. E., and Cobb, M. H. (1997) Cross-cascade activation of ERKs and ternary complex factors by Rho family proteins. EMBO J. 16, 6426-6438
72. Gopalbhai, K., Jansen, G., Beauregard, G., Whiteway, M., Dumas, F., Wu, C., and Meloche, S. (2003) Negative regulation of MAPKK by phosphorylation of a conserved serine residue equivalent to Ser212 of MEK1. J. Biol. Chem. 278, 8118-8125
73. Girault, J. A., Valjent, E., Caboche, J., and Hervé, D. (2007) ERK2: a logical AND gate critical for drug-induced plasticity? Curr. Opin. Pharmacol. 7, 77-85
74. Paul, S., Nairn, A. C., Wang, P., and Lombroso, P. J. (2003) NMDA-mediated activation of the tyrosine phosphatase STEP regulates the duration of ERK signaling. Nat. Neurosci. 6, 34-42
75. Shors, T. J., and Mathew, P. R. (1998) NMDA receptor antagonism in the lateral/basolateral but not central nucleus of the amygdala prevents the induction of facilitated learning in response to stress. Learn. Mem. 5, 220-230
76. Einat, H., Yuan, P., Gould, T. D., Li, J., Du, J., Zhang, L., Manji, H. K., and Chen, G. (2003) The role of the extracellular signal-regulated kinase signaling pathway in mood modulation. J. Neurosci. 23, 7311-7316
77. Todorovic, C., Sherrin, T., Pitts, M., Hippel, C., Rayner, M., and Spiess, J. (2009) Suppression of the MEK/ERK signaling pathway reverses depressionlike behaviors of CRF2-deficient mice. Neuropsychopharmacology 34, 1416-1426
78. Tronson, N. C., Schrick, C., Fischer, A., Sananbenesi, F., Pagès, G., Pouysségur, J., and Radulovic, J. (2008) Regulatory mechanisms of fear extinction and depression-like behavior. Neuropsychopharmacology 33, 1570-1583
79. Réus, G. Z., Vieira, F. G., Abelaira, H. M., Michels, M., Tomaz, D. B., Dos Santos, M. A., Carlessi, A. S., Neotti, M. V., Matias, B. I., Luz, J. R., Dal-Pizzol, F., and Quevedo, J. (2014) MAPK signaling correlates with the antidepressant effects of ketamine. J. Psychiatr. Res. 55, 15-21